Want to join the conversation?
Irving, Texas-based $CMC posted lower earnings in 3Q16, hurt by lower revenues compared to 3Q15. Net earnings attributable to CMC for 3Q16 were $19.3MM or $0.17 per diluted share versus $28.7MM or $0.25 per diluted share for 3Q15. Net sales decreased to $1.2Bil from $1.5Bil last year.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?